SENEX BIOTECHNOLOGY, INC.

Making Cancers Curable

Columbia, United States · Founded 2015 · $2.0M raised

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$2.0M
Last Round
$1.6M GrantSep 2022
Rounds
2

About

Senex Biotechnology is a clinical-stage company developing highly selective CDK8/19 Mediator Kinase inhibitors to prevent cancer drug resistance and metastasis. Its lead candidate SNX631-6, an orally available small molecule, targets castration-resistant prostate cancer and breast cancer, supported by Department of Defense and NIH grant funding.

Summary

SENEX BIOTECHNOLOGY, INC. is a Biotech company based in Columbia, United States, founded in 2015. It has raised $2.0M in total across 2 rounds, most recently a $1.6M Grant round in Sep 2022. Investors include National Institutes of Health, National Cancer Institute and National Heart, Lung, and Blood Institute.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

GrantSep 2022
$400K

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SENEX BIOTECHNOLOGY, INC. on Indexed.vc
<a href="https://indexed.vc/companies/senex-biotechnology-inc"><img src="https://indexed.vc/api/badge/company/senex-biotechnology-inc" alt="SENEX BIOTECHNOLOGY, INC. on Indexed.vc" width="260" height="76" /></a>